RecruitingNot ApplicableNCT07308418

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

Sponsor

Magnes AG

Enrollment

16 participants

Start Date

Jan 10, 2026

Study Type

INTERVENTIONAL

Conditions

Parkinson's Disease (PD)

Summary

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether vibrotactile stimulation — gentle vibrations delivered to the body as a rhythmic cue — can help people with Parkinson's disease naturally choose a faster, more normal walking speed during everyday movement. **You may be eligible if...** - You have a confirmed medical diagnosis of Parkinson's disease - Your medication (dopaminergic therapy) has been stable for at least four weeks - You can walk at least 200 metres without stopping - You are at least 18 years old - You understand German well enough to read study information and fill in questionnaires **You may NOT be eligible if...** - You have atypical or secondary Parkinsonism (Parkinson's caused by another condition) - You have sensory problems in your feet (e.g., nerve damage/polyneuropathy) - You have other neurological, orthopedic, or serious medical conditions affecting mobility Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.